BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement
BridgeBio to Acquire All Outstanding Shares of Eidos it Does Not Already OwnAgreement Brings BridgeBio’s Clinical Development and Commercial Development […]
Hamilton Lane Named International LP of the Year by Private Equity Women Investor Network
BALA CYNWYD, Pa., Oct. 05, 2020 (GLOBE NEWSWIRE) — Leading private markets asset management firm Hamilton Lane (NASDAQ: HLNE) was […]
ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer
LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 05, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company […]
Apellis Initiates Registrational Programs of Pegcetacoplan in Patients with C3G / IC-MPGN and ALS, Rare Diseases with High Unmet Need
Advancing Phase 2 and Phase 3 studies of the company’s targeted C3 therapy in C3G / IC-MPGN, rare kidney diseases […]
Forterra Announces Rating Upgrade by S&P
IRVING, Texas, Oct. 05, 2020 (GLOBE NEWSWIRE) — Forterra, Inc. (“Forterra” or “the Company”) (NASDAQ: FRTA), a leading manufacturer of […]
Cyclacel Pharmaceuticals to Present at the October 2020 Lytham Partners Virtual Investor Growth Conference
BERKELEY HEIGHTS, N.J., Oct. 05, 2020 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a [...]
LGI Homes Reports Preliminary September 2020 Home Closings
THE WOODLANDS, Texas, Oct. 05, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) in advance of investor meetings, today […]
Fulcrum Therapeutics to Initiate Phase 1 Trial with FTX-6058 for Sickle Cell Disease
CAMBRIDGE, Mass., Oct. 05, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives […]
Trevena, Inc. Announces Three OLINVYK™ Presentations at the Virtual American Society of Anesthesiologists 2020 Annual Meeting
—Posters highlight improvements in respiratory safety and gastrointestinal tolerability associated with OLINVYK (oliceridine) injection vs. IV morphine—CHESTERBROOK, Pa., Oct. 05, [...]
Axovant to Participate in Upcoming October Conferences and Provide AXO-Lenti-PD Program Update the Morning of October 6th
NEW YORK, Oct. 05, 2020 (GLOBE NEWSWIRE) — Axovant Gene Therapies Ltd. (Nasdaq: AXGT), a clinical-stage company developing innovative gene […]
